Regenerative Medical Technology Group Inc.
RMTG
$0.0531
$0.00316.20%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 23.98% | 66.99% | 145.42% | 52.49% | 119.51% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 23.98% | 66.99% | 145.42% | 52.49% | 119.51% |
Cost of Revenue | 49.29% | 69.52% | 193.47% | 21.73% | 147.81% |
Gross Profit | 11.18% | 65.89% | 125.44% | 65.91% | 107.60% |
SG&A Expenses | 16.76% | 31.83% | 32.78% | 49.67% | 1.63% |
Depreciation & Amortization | -33.98% | -32.38% | -128.69% | -10.03% | 43.35% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 21.29% | 36.77% | 50.71% | 33.87% | 24.57% |
Operating Income | -10.12% | 265.04% | 388.19% | 131.73% | 55.48% |
Income Before Tax | 37.12% | 61.24% | -149.30% | 84.85% | -2.29% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 37.12% | 61.24% | -149.30% | 84.85% | -2.29% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 37.12% | 61.24% | -149.30% | 84.85% | -2.29% |
EBIT | -10.12% | 265.04% | 388.19% | 131.73% | 55.48% |
EBITDA | -44.06% | 3,624.53% | 1,320.33% | 332.05% | 70.92% |
EPS Basic | 37.36% | 61.40% | -147.09% | 84.96% | -1.90% |
Normalized Basic EPS | 37.34% | 61.37% | 64.11% | 49.20% | -1.86% |
EPS Diluted | 37.36% | 61.40% | -147.09% | 84.96% | -1.90% |
Normalized Diluted EPS | 37.34% | 61.37% | 64.11% | 49.20% | -1.86% |
Average Basic Shares Outstanding | 0.36% | 0.36% | 0.66% | 0.76% | 0.40% |
Average Diluted Shares Outstanding | 0.36% | 0.36% | 0.66% | 0.76% | 0.40% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |